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ABSTRACT
Intra-articular injected hyaluronic acid provides pain relief and functional improvements in patients with 
gonarthrosis. We present a 92-year-old woman with iatrogenic blue toe syndrome after intra-articular in-
jection of hyaluronic acid. This is an anecdotally rare complication, which aims to heighten the clinician’s 
awareness on the possible intervention pitfalls and spectrum of therapeutic indications. 
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INTRODUCTION
Intra-articular injected hyaluronic acid pro-
vides pain relief and functional improvements in pa-
tients with gonarthrosis (1). The treatment has been 
highly recognized since 1997 as a first-line interven-
tional therapy, which has a good pain-reducing ef-
fect, improving synovial oxygen partial pressure, in-
tra-articular temperature and Lequesne score (2). A 
few side effects, mostly related to the technique of the 
intervention, have been described (3).
Herein, a unique case of blue toe syndrome upon 
intra-articular hyaluronic acid intervention is re-
ported. The special therapeutic indications and pos-
sible intervention pitfalls are thoroughly discussed. 
CASE REPORT
A 92-year-old woman presented to the Derma-
tology Department with severe pain and violent dis-
coloration of the volar aspect of the right lower leg 
and toes. A week prior to admission she had under-
gone bilateral intra-articular administration of hyal-
uronic acid, which was done to improve functional 
parameters and to reduce the pain from a long-last-
ing destructive gonarthrosis. During the procedure 
she complained of sudden discomfort followed by se-
vere pain localized to the back of the right foot. Sub-
sequent grey discoloration of the great toe appeared 
and spread to the third and fourth toes of the same 
foot overnight.  The ischemic lesions continued to 
grow, became confluent, and caused unbearable 
pain.  The patient was, otherwise, known to be in 
perfect health, with no hypercholesterolemia, isch-
emic heart disease and congestive cardiac failure. She 
was a non-smoker and regularly took only food sup-
plements to enhance her cognition. 
Examination revealed purple discoloration of 
the right great, third and fourth toes with evidence 
of digital infarctions (Fig.1). Deep well-demarcated 
necrosis localized to the tip of the great toe, the distal 
margin of the nail plate and nail bed was seen. Star-
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The presence of pedal pulses with digital in-
farction suggested small vessel disease. Therefore, 
the possibility of small arterioles hyaluronic acid em-
bolization upon the intra-articular intervention was 
hypothesized. Pentoxifylline was introduced for 1 
month in combination with topical dressings and ap-
propriate antiseptic care. Demarcated areas of necro-
sis were removed surgically and secondary epitheli-
alization was achieved in the following 3 months.  
DISCUSSION
Blue toe syndrome is a well-recognized but 
probably underdiagnosed disorder, in which most 
commonly cholesterol crystals embolize from ath-
erosclerotic plaques and occlude peripheral arte-
rioles (4). The reported incidence is variable, rang-
ing from 6.2 cases per million population per year to 
one case every two weeks (5,6). The typical patient is 
an elderly male with a history of hypertension and 
atherosclerotic disease (7). The more cardiovascu-
lar atherosclerotic factors are present, the more like-
ly the diagnosis is. Although the condition can occur 
spontaneously, very often it affects subjects with se-
vere generalized atherosclerotic disease. 
Iatrogenic interventions, alone or in combined 
regimens with antithrombolytic and anti-coagula-
tion drugs, are recognized precipitants of blue toe 
syndrome. Mechanical disruption of thrombus over-
lying atheroma, e.g., following angiography, angio-
plasty or vascular surgery is very likely to occur (8). 
During the intervention the plaque is exposed to the 
general circulation and goes to the small-diameter 
arteries (9). The increasing use of these techniques 
should increase the vigilance for the more frequent 
development of blue toe syndrome. 
The vasculature of the lower leg consists of 
many collaterals, which join in two profound cir-
cles around the knee joint and ankle (10). The main 
arterial branch on the back of the foot derives from 
a.tibialis anterior. Presumably, during the intra-ar-
ticular intervention of the right knee joint, small 
amounts of hyaluronic acid was injected to one of the 
two recurrent tibial arteries and introduced to the 
anterior tibial artery. Apart from malpractice, an-
other possible reason for the developing of the con-
dition in our patient may be an anatomic variation 
of a branch of the anterior tibial artery, present only 
in her right lower leg. Such a peculiarity could ex-
like necrotic changes spread on the volar aspect of the 
calf (Fig.2). Her blood pressure was 120/80 mmHg 
and no murmurs or bruits were audible. Lower limb 
pulses were all palpable and Doppler pressure studies 
suggested small vessel occlusion without significant 
large vessel disease. Investigations revealed: hemo-
globin 13.2 g/dl, platelets 346x109/1, erythrocyte sed-
imentation rate (ESR) 26 mm/h, white blood cells 9.5 
x 109/1 (neutrophils 4.6, lymphocytes 1.3, monocytes 
0.6, eosinophils 0. 1, basophils 0. 1). Na 141 mmol/l, K 
4.7 mmol/l, urea 12.1 mmol/l, creatinine 169 mmol/l, 
cholesterol 3.6 mmol/l, auto-immune profile and 
ANCA negative. Electrocardiogram showed no path-
ological changes. Echocardiography and abdominal 
ultrasound were within normal ranges. 
Fig. 1. Purple discoloration of the right great, third and 
fourth toes with evidence of digital infarctions
Fig. 2. Star-like necrotic changes spread on the volar as-
pect of the calf
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plain the very unusual presentation of the blue toe 
syndrome described.
The clinical picture of blue toe syndrome pres-
ents with lower extremity pain, livedo reticularis, 
purpura, cyanosis, “purple toes”, and cutaneous ne-
crosis (11). Fever, myalgia, weight loss, gastrointesti-
nal bleeding, vascular bruits, encephalopathy, altered 
mental state, and pancreatitis could also be seen in 
the extended disease (12). Laboratory features consist 
of elevated erythrocyte sedimentation rate, throm-
bocytopenia, abnormal liver function tests and cre-
atine kinase, elevated serum urea and creatinine, and 
hypocomplementemia (13). If at all possible, the di-
agnosis should be confirmed histologically by tissue 
biopsy of the skin to reveal embolization of the arte-
rioles. In our case the old age of the patient and the 
lack of compliance avoided histological verification. 
The differential diagnosis ruled out systemic vascu-
litis, cholesterol emboli, and drug-induced leukocy-
toclastic vasculitis. The clinical features of ischemic 
necrosis with lack of palpable purpura and edema, 
however, concluded the diagnosis and optimized 
complex therapeutic measures. Such side effect of in-
tra-articular intervention is anecdotally rare, and has 
not been reported before.
CONCLUSION
Clinicians should have a heightened awareness 
of blue toe syndrome as a possible side effect of in-
tra-articular interventions. In these cases the disease 
bears the same clinical characteristics as cholester-
ol crystal embolism, which has to be ruled out. Anti-
platelet therapy and rheological medications, togeth-
er with appropriate topical dressings, should be ap-
plied in the complex therapeutic regimen for these 
patients.
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